DocDollars

Celularity Inc.

NJ · United States · Reporting entity ID 100000246809

Total reported 2019–2025
$7.51M
#580 of 2,960 reporting companies — 0% of all reported industry payments
$3.59M in general payments across 3,218 records, plus $3.91M in research funding across 114 records.

How it breaks down

General payments $3,592,642
Research funding $3,905,197
Ownership & investment $9,289

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Celularity Inc. reported $7.51M to US doctors and teaching hospitals from 2019 to 2025, ranking #580 of 2,960 reporting companies. 52% of that was research funding and 48% general payments such as consulting, speaking, food and travel. 3,218 general payment records and 114 research records were filed.

Common questions about Celularity Inc.

How much has Celularity Inc. paid US doctors?

Celularity Inc. reported $7,507,127 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,592,642 in general payments, $3,905,197 in research funding and $9,289 in ownership and investment interests.

How does Celularity Inc. rank among drug and device companies?

It ranks #580 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Celularity Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.